Biotechnology
Corbus Pharmaceuticals Stock Continues to Grow
Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) continues to impress investors since the start of this year, resulting in share price appreciation of more than 26% in the last month alone. CRBP stock is currently trading around $9 ... [Read]
Biotechnology
Two Biotechnology Stocks Trading Higher Today: Capricor Therapeutics and RedHill Biopharma
If you’re looking for a particular industry to start investing in, why not consider the healthcare industry? Sure, cryptocurrency or technology might be a tad bit more exciting, but let us not forget that the ... [Read]
Biotechnology
Why is Iovance Biotherapeutics Up Nearly 30% Today?
January is a month of new beginnings. For some, it means ridding themselves of flaws and putting into action various resolutions moving forward with the new year. For the stock market, it means there are ... [Read]
Biotechnology
MannKind Shares Soar, Afrezza and Cash Position in Focus
MannKind Corporation (NASDAQ:MNKD) shares generated growth of 40% in Thursday’s trade and the stock is up 15% since the start of this year. Although no report accounts for a huge rally in Thursday’s trade, traders ... [Read]
Biotechnology
Zymeworks Inc. Stock Soars; Here’s What to Expect
After declining sharply in the mid of the last year, Zymeworks Inc. (TSX:ZYME) (NASDAQ:ZYME) shares bounced back significantly last month, thanks to strong results related to its Phase 1 dose-escalation study. ZYME stock gained more ... [Read]
Biotechnology
Bullish Sentiments are Rising for Fate Therapeutics Stock Price
Fate Therapeutics Inc. (NASDAQ:FATE) shares continue to extend the momentum in Tuesday trade, supported by investors bullish bets on its future fundamentals and advancement in key pipeline products. Fate Therapeutics shares improved 14% in Tuesday’s ... [Read]
Biotechnology
Why Inovio Pharmaceuticals is Up Nearly 30% Today
Sure, most of the world might be focusing on the fact that Bitcoin climbed above the $11,000 mark today, despite Goldman Sachs (NYSE:GS) sending out a warning to investors that the digital currency is a ... [Read]
Biotechnology
Idera Pharmaceuticals Stock Plunges 20% – Here’s Why
Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is under investigation by Levi & Korsinsky, LLP, an established firm in securities litigation. What happened? Earlier in the day, it was announced that Idera Pharmaceuticals would be merging with BioCryst ... [Read]
Biotechnology
Are Companies Looking at Acorda Therapeutics as a Potential Takeover Target?
Two months ago, New York-based Acorda Therapeutics (NASDAQ:ACOR) had to discard its late-stage drug tozadenant due to five patients passing away in a clinical trial. At the time, this looked like it was going to ... [Read]
Biotechnology
Diffusion Pharmaceuticals Discloses $12M Underwritten Public Offering, Stock Plunges Nearly 40%
Last week, Diffusion Pharmaceuticals (NASDAQ:DFFN), a clinical-stage biotechnology company based in Charlottesville, Virginia, soared nearly 40% on the market after CEO David Kalergis presented an overview of the company to the crowd at San Francisco’s ... [Read]